FDA approves Roche food allergy drug
In 2021, Danish company ALK announced its entry into the food allergy treatment market.
The US Food and Drug Administration (FDA) has approved preventive treatment with Xolair (omalizumab) from Roche to reduce allergic reactions, including anaphylaxis, following the consumption of certain foods in patients from 1 year of age, Roche writes in a stock exchange announcement.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
